Microneedle manufacturing method

The simultaneous pressurization and drying method in a pressurizing chamber addresses quantitative deviations in biodegradable microneedle manufacturing, enhancing process efficiency and reducing contamination, thereby improving microneedle production quality and yield.

JP2024541747AActive Publication Date: 2024-11-11DAEWOONG THERAPEUTICS INC
View PDF 8 Cites 0 Cited by

Patent Information

Application Number
JP2024551879
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2021-12-14
Filing Date
2022-04-04
Publication Date
2024-11-11
Estimated Expiration
2042-04-04

AI Technical Summary

Technical Problem

Conventional methods for manufacturing biodegradable microneedles suffer from quantitative deviations due to pharmacological components overflowing and air bubbles bursting during depressurization, leading to contamination and process inefficiencies.

Method used

A method involving simultaneous pressurization and drying processes in a pressurizing chamber to fill and dry the pharmacological component within the microneedle mold, using controlled air injection and discharge to create a convection phenomenon, ensuring precise filling and drying.

Benefits of technology

This approach simplifies the manufacturing process, improves quantitative accuracy, reduces contamination risk, and enhances productivity by forming large quantities of microneedles with improved quality.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024541747000001_ABST
    Figure 2024541747000001_ABST
Patent Text Reader

Abstract

One embodiment of the present invention provides a method for manufacturing microneedles, comprising the steps of applying a raw material containing a pharmacological ingredient to one or more recesses formed in a microneedle mold, and entering the microneedle mold with the applied raw material into a pressure chamber and pressurizing the raw material at the internal pressure of the pressure chamber to fill the raw material into the microstructures of the recesses, wherein the pressurizing step simultaneously injects and expels air into the pressure chamber, causing a convection phenomenon within the pressure chamber to simultaneously fill and dry the raw material.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to a method for manufacturing a microneedle, and more particularly, to a method for manufacturing a microneedle in which a pharmacological ingredient applied to a microneedle mold is subjected to a pressurizing and drying process simultaneously to simplify the process and improve the quantitative accuracy of the pharmacological ingredient. [Background technology]

[0002] Generally, microneedle dosage forms aim to deliver ingredients to achieve a desired effect through the skin. Microneedle dosage forms use microneedles with a diameter and height of only tens to thousands of micrometers to break through the stratum corneum, which is the main barrier layer for ingredient delivery through the skin. The microneedles are used to deliver the desired ingredient to the epidermis or dermis, and the ingredient exerts its effect throughout the body through the site where the microneedles are applied or the circulatory system of the human body.

[0003] Microneedles can be broadly divided into metal microneedles and microneedles made of biodegradable materials.

[0004] Metallic microneedles come in two types: hollow microneedles, which have a hollow space like a general injection needle and have a path through which the ingredient to be delivered can move, and solid microneedles, which deliver the ingredient by coating it on the surface of the microneedle.

[0005] Meanwhile, biodegradable microneedles are mainly in the form of solid microneedles, and are prepared by coating the surface of the microneedle with ingredients or forming a microneedle with a biodegradable polymer and applying it to the skin, and then delivering the ingredients as the applied microneedle decomposes. The biodegradable microneedles are generally manufactured by injecting a pharmacological ingredient that constitutes the microneedle into a mold in which the shape of the microneedle is engraved.

[0006] At this time, as shown in FIG. 1, a conventional method for manufacturing biodegradable microneedles includes a process of applying a pharmacological ingredient onto a mold, a process of infiltrating the pharmacological ingredient into the microstructure inside the mold in a reduced pressure or vacuum environment, and a process of drying the pharmacological ingredient inside the mold to form a microneedle.

[0007] However, such conventional methods for manufacturing biodegradable microneedles have problems such as the escape of pharmacological ingredients and air bubbles in the mold during the decompression or vacuum process (air bubbles burst and the pharmacological ingredients overflow into the mold intaglio). This can result in quantitative deviations in the pharmacological ingredients in the microneedles.

[0008] Prior art documents Korean Patent Registration No. 10-1747099 (2017.06.08) Summary of the Invention [Problem to be solved by the invention]

[0009] The present invention is intended to solve the problems of the prior art described above, and the object of the present invention is to provide a method for manufacturing microneedles that simplifies the process by simultaneously performing compression and drying processes on a pharmacological ingredient applied to a microneedle mold, thereby improving the quantitative accuracy of the pharmacological ingredient. [Means for solving the problem]

[0010] In order to achieve the above-mentioned objectives, one aspect of the present invention provides a method for manufacturing microneedles, comprising the steps of applying a raw material containing a pharmacological ingredient to one or more recesses formed in a microneedle mold, and entering the microneedle mold with the applied raw material into a pressure chamber and pressurizing the raw material at the internal pressure of the pressure chamber to fill the raw material into the microstructures of the recesses, wherein the pressurizing step simultaneously injects and expels air into the pressure chamber, causing a convection phenomenon within the pressure chamber to simultaneously fill and dry the raw material.

[0011] In one embodiment of the present invention, the method for manufacturing a microneedle may be characterized in that, when the pressure of the air injected into the pressurized chamber is X bar and the pressure of the air discharged from the pressurized chamber is Y bar, the internal pressure XY bar of the pressurized chamber is 1.5 bar or more.

[0012] In one embodiment of the present invention, the method for manufacturing a microneedle may be characterized in that the pressure of the air injected into the pressure chamber is 2 bar or more, and the pressure of the air discharged from the pressure chamber is 0.5 bar or more.

[0013] In one embodiment of the present invention, the method for manufacturing a microneedle may be characterized in that the microneedle mold is manufactured by injection molding a thermoplastic resin.

[0014] In one embodiment of the present invention, the method for manufacturing microneedles may be characterized in that the thermoplastic resin is at least one selected from the group consisting of polyethylene terephthalate (PET), polyvinyl chloride (PVC), and polypropylene (PP).

[0015] In one embodiment of the present invention, the method for manufacturing a microneedle may be characterized in that the recessed portions of the microneedle mold are tip recessed portions and exist independently of each other.

[0016] In order to achieve the above-mentioned object, another aspect of the present invention provides a method for manufacturing microneedles, comprising the steps of placing a number of microneedle molds on a jig, applying a raw material containing a pharmacological ingredient to one or more engraved portions formed on the microneedle mold, fixing one or more of the jigs to a tray, and entering the tray into a pressure chamber and pressurizing the raw material with the internal pressure of the pressure chamber to fill the raw material into the microstructures of the engraved portions, wherein the pressurizing step simultaneously injects and expels air into the pressure chamber, causing a convection phenomenon within the pressure chamber to simultaneously fill and dry the raw material.

[0017] In one embodiment of the present invention, the method for manufacturing a microneedle may be characterized in that, when the pressure of the air injected into the pressurized chamber is X bar and the pressure of the air discharged from the pressurized chamber is Y bar, the internal pressure XY bar of the pressurized chamber is 1.5 bar or more.

[0018] In one embodiment of the present invention, the method for manufacturing a microneedle may be characterized in that the pressure of the air injected into the pressure chamber is 2 bar or more, and the pressure of the air discharged from the pressure chamber is 0.5 bar or more. Effect of the Invention

[0019] According to one aspect of the present invention, the method of manufacturing a microneedle of the present invention simplifies the process by simultaneously performing a pressurizing and drying process in a pressurizing chamber on the raw material applied to the recessed portion of the microneedle mold, thereby improving the quantitativeness of the raw material and reducing the possibility of contamination of the microneedle by reducing exposure to the external environment during the manufacturing process.

[0020] Furthermore, microneedles can be mass-formed within a pressurized chamber by using a jig on which a large number of microneedle molds can be arranged and a tray on which a large number of jigs can be fixed, which can improve the productivity of microneedles.

[0021] It should be understood that the effects of the present invention are not limited to the effects described above, but include all effects that can be inferred from the configuration of the invention described in the detailed description of the present invention or the claims. [Brief description of the drawings]

[0022] [Figure 1] 1 is a diagram conceptually showing a method for manufacturing a microneedle according to a conventional technique. [Diagram 2] 1 is a flowchart of a method for manufacturing a microneedle according to an embodiment of the present invention. [Diagram 3] 1 is a conceptual diagram illustrating a method for manufacturing a microneedle using a point application method within a recessed portion of a mold according to an embodiment of the present invention. [Figure 4] 1 is a conceptual diagram illustrating a method for manufacturing a microneedle in a case where a whole mold coating method is used in accordance with an embodiment of the present invention. [Diagram 5] 10 is a flowchart of a method for manufacturing a microneedle according to another embodiment of the present invention. [Figure 6] 13 is a conceptual diagram illustrating a method for manufacturing a microneedle using a point application method in a recessed portion of a mold according to another embodiment of the present invention. [Figure 7] 13 is a conceptual diagram illustrating a method for manufacturing a microneedle in a case where a whole mold coating method is used in accordance with another embodiment of the present invention. [Figure 8] An example will be given showing whether or not microneedles are generated for each polymer depending on the internal pressure of the pressure chamber. [Figure 9] An example will be given showing whether or not microneedles are generated for each polymer depending on the internal pressure of the pressure chamber. [Figure 10] An example will be given showing whether or not microneedles are generated for each polymer depending on the internal pressure of the pressure chamber. [Figure 11] An example will be given showing whether or not microneedles are generated for each polymer depending on the internal pressure of the pressure chamber. [Figure 12]An example will be given showing whether or not microneedles are generated for each polymer depending on the internal pressure of the pressure chamber. [Figure 13] An example will be given showing whether or not microneedles are generated for each polymer depending on the internal pressure of the pressure chamber. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0023] Hereinafter, the present invention will be described with reference to the accompanying drawings. However, the present invention may be embodied in various different forms and is not limited to the embodiments described herein. In order to clearly explain the present invention in the drawings, parts that are not related to the description are omitted, and similar parts are designated by similar reference numerals throughout the specification.

[0024] Throughout the specification, when a part is described as being "connected" to another part, this includes not only the case where the part is "directly connected" to another part, but also the case where the part is "indirectly connected" to another part through another member in between. Furthermore, when a part is described as "comprising" some component, this does not mean that the part excludes other components, but that the part may further comprise other components, unless otherwise specified.

[0025] DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS Hereinafter, preferred embodiments of the present invention will be described in detail with reference to the accompanying drawings.

[0026] FIG. 2 is a flowchart of a method for manufacturing a microneedle according to one embodiment of the present invention, FIG. 3 is a conceptual diagram of a method for manufacturing a microneedle when a point coating method is used within a recessed portion of a mold according to one embodiment of the present invention, and FIG. 4 is a conceptual diagram of a method for manufacturing a microneedle when a coating method is used over the entire mold according to one embodiment of the present invention.

[0027] 2 to 4, the microneedle manufacturing method of the present invention includes a step of preparing a microneedle mold 100 (S110), a step of applying a raw material 120 to the engraved portion 110 of the microneedle mold 100 (S120), and a step of pressurizing, filling and drying the raw material 120 in a pressure chamber 30 (S130).

[0028] More specifically, the microneedle manufacturing method of the present invention includes a step (S110) of preparing a microneedle mold 100, a step (S120) of applying a raw material 120 containing a pharmacological ingredient to one or more engraved portions 110 formed on the microneedle mold 100, and a step (S130) of inserting the microneedle mold 100 with the applied raw material 120 into a pressure chamber 30 and pressurizing the raw material 120 at the internal pressure of the pressure chamber 30 to fill the raw material 120 into the microstructures 111 of the engraved portions 110, and the pressurizing step (S130) is configured to simultaneously inject and exhaust air into the pressure chamber 30, causing a convection phenomenon within the pressure chamber 30 to simultaneously fill and dry the raw material 120.

[0029] In the step of preparing the microneedle mold 100 (S110), the microneedle mold 100 including one or more recessed portions can be manufactured by injection molding through a process of melting, flowing, cooling, and demolding a thermoplastic resin using an injection device. At this time, one side of the microneedle mold 100 may include one or more recessed portions 110, and the other side may be flat. The recessed portions 110 act as a mold for the microneedles formed in the subsequent step, and may have the same shape as the microneedles.

[0030] In this case, the engraved portion 110 may include a tip engraved portion. The term "tip engraved portion" used in this specification means an intaglio portion that is recessed from a flat upper surface to a lower surface forming a tip, with a cross-sectional area decreasing from the upper surface to a lower surface forming a tip, so as to have a typical microneedle shape. The terms "upper surface" and / or "lower surface" used in this specification are intended to specify the relative positional relationship of each component, and are not intended to specify their absolute positions.

[0031] Meanwhile, the microneedle mold 100 may be made of a solid material. The microneedle mold 100 may be made of any suitable material, but is preferably made of a plastic resin.

[0032] More specifically, the microneedle mold 100 may be at least one selected from the group consisting of polyethylene terephthalate (PET), polyvinyl chloride (PVC), and polypropylene (PP), but is not limited thereto.

[0033] Conventional silicon materials are expensive, so they are burdensome to use as disposable materials and need to be reused, but in this case, it is difficult to verify the cleaning validation (CV) of the minute recessed part where the microneedles are molded and the silicon permeability of the cleaning solvent.In addition, silicon materials are decomposed physicochemically and have a relatively weak hardness, so it is difficult to verify the generation of debris during the manufacturing or cleaning process and the lifespan of the silicon mold.

[0034] In addition, in the mold manufacturing method using silicone material, the silicone cannot protect against external air or foreign objects, so the dried microneedles must be removed from the silicone mold and then repackaged. In this process, since it is practically difficult to individually and tightly pack the microneedles due to their minute size, the microneedles must be packaged in a pouch exposed to air or in a cap-like container.

[0035] Since the closure and stability of the packaging container are factors that have a huge impact on maintaining the quality of the internal medicine, it is necessary to completely protect the internal microneedle medicine from physical and chemical deformation and deterioration through simulation of the final product transportation conditions and mechanical testing.

[0036] The microneedle mold 100 of the present invention can function as a primary packaging container that is completely attached to the microneedle, without the need to remove and repackage the microneedle formed in the engraved portion 110, and can be configured in a form that can be removed before use. This simplifies the packaging process of the microneedle and makes it easier to maintain the quality of the microneedle.

[0037] In the step (S120) of applying the raw material 120 to the engraved portions 110 of the microneedle mold 100, the raw material 120 may be supplied from a storage tank to the microneedle mold 100 through a single discharge portion to be applied to the engraved portions 110. However, the method of applying the raw material 120 is not limited thereto, and the raw material 120 may be applied to the engraved portions 110 through a plurality of discharge portions positioned adjacent to each of the plurality of engraved portions 110, as necessary.

[0038] At this time, referring to FIG. 3 and FIG. 4, the application of the raw material 120 can be performed by applying one or more drops only to each of the engraved portions 110, or by applying the raw material 120 to the entire upper surface of the microneedle mold 100 on which the engraved portions 110 are formed. The raw material 120 may include at least one selected from the group consisting of metals, non-metals, biodegradable polymers, and active pharmaceutical ingredients depending on the application of the microneedle. For example, the raw material 120 may be a composition containing a pharmacological ingredient, and may be, but is not limited to, a composition containing a metal, a non-metal, a biodegradable polymer, or a combination of two or more of these.

[0039] In the step of pressurizing the raw material 120 applied to the engraved portion 110 in the pressurizing chamber 30 (S130), the raw material 120 is pressurized using the internal pressure of the pressurizing chamber 30 in order to fill the raw material 120 into the microstructure 111 of the engraved portion 110.

[0040] When air is injected through the inlet 31 of the pressurizing chamber 30 while the pressurizing chamber 30 is sealed and the pressure in the pressurizing chamber 30 increases, the raw material 120 is pressurized by the gas pressure inside the pressurizing chamber 30, and the microscopic air bubbles contained in the raw material 120 are naturally removed by being released from the raw material 120, and the raw material 120 is filled into the microstructure 111 in the engraved portion 110.

[0041] At this time, air is discharged through the exhaust port 32 of the pressurizing chamber 30 at the same time, so that convection occurs within the pressurizing chamber 30 and the raw material 120 can be dried at the same time.

[0042] In other words, the microneedle manufacturing method of the present invention simplifies the process by simultaneously performing pressurization and drying processes in the pressurization chamber 30 on the raw material 120 applied to the engraved portion 110 of the microneedle mold 100, thereby improving the quantitativeness of the raw material 120 and reducing the possibility of contamination of the microneedles by reducing exposure to the external environment during the manufacturing process.

[0043] Meanwhile, when the pressure of the air injected into the pressurized chamber 30 through the inlet 31 is X bar and the pressure of the air discharged from the pressurized chamber 30 through the outlet 32 ​​is Y bar, the internal pressure XY bar of the pressurized chamber 30 may be 1.5 bar or more, preferably 2 bar or more.

[0044] Also, the pressure of the air injected into the pressurized chamber 30 may be 2 bar or more, preferably 2.5 bar or more, and the pressure of the air discharged from the pressurized chamber 30 may be 0.5 bar or more.

[0045] That is, while air is injected and discharged from the pressurizing chamber 30 at the same time, the internal pressure of the pressurizing chamber 30 is maintained at 1.5 bar or more, preferably 2 bar or more, so that the raw material 120 can be smoothly filled and dried. If the internal pressure of the pressurizing chamber 30 is less than 1.5 bar, the raw material 120 cannot be smoothly filled into the microstructure 111 in the engraved portion 110, and the micro bubbles contained in the raw material 120 may not be naturally released from the raw material 120.

[0046] Figure 5 is a flowchart of a microneedle manufacturing method according to another embodiment of the present invention, Figure 6 is a conceptual diagram of a microneedle manufacturing method in the case of a point coating method within the recessed portion of a mold according to another embodiment of the present invention, and Figure 7 is a conceptual diagram of a microneedle manufacturing method in the case of an entire mold coating method according to another embodiment of the present invention.

[0047] The following description will focus on differences or additions from the above-described embodiment.

[0048] 5 to 7, the method for manufacturing microneedles according to the present invention includes a step of preparing a microneedle mold 100 (S210), a step of placing a number of microneedle molds 100 on a jig 10 (S220), a step of applying raw material 120 to the engraved portion 110 of the microneedle mold 100 (S230), a step of fixing one or more of the jigs 10 to a tray 20 (S240), and a step of inserting the tray 20 into a pressurizing chamber 30 and pressurizing the raw material 120 with the internal pressure of the pressurizing chamber 30 to fill the raw material 120 into the microstructures 111 of the engraved portion 110 (S250). The pressurizing step (S250) is configured to simultaneously inject and exhaust air into and from the pressurizing chamber 30, thereby causing a convection phenomenon within the pressurizing chamber 30 to simultaneously fill and dry the raw material 120.

[0049] In the step of placing a number of microneedle molds 100 on the jig 10 (S220), the jig 10 may be formed in a plate shape and may have a number of mounting portions (not shown) on the upper surface on which the microneedle molds 100 can be positioned. The mounting portions may be formed of a groove structure having a shape corresponding to the shape of the microneedle molds 100.

[0050] The jig 10 may be configured so that the microneedle molds 100 can be placed in a form of N×M (where N and M are numbers), and a total of N×M microneedle molds 100 can be placed on one jig 10.

[0051] In the step of applying the raw material 120 to the engraved portions 110 of the microneedle mold 100 (S230), the raw material 120 may be supplied from a storage tank to the microneedle mold 100 through a single discharge portion to be applied to the engraved portions 110. However, the method of applying the raw material 120 is not limited thereto, and the raw material 120 may be applied to the engraved portions 110 through a plurality of discharge portions positioned adjacent to each of the plurality of engraved portions 110, as necessary.

[0052] At this time, referring to Figures 6 and 7, the application of the raw material 120 can be performed by applying one or more drops only to each of the engraved portions 110, or by applying the raw material 120 to the entire upper surface of the microneedle mold 100 on which the engraved portions 110 are formed.

[0053] In the step of fixing one or more jigs 10 to the tray 20 (S240), the tray 20 may be a multi-tiered tray, and multiple jigs 10 may be fixed in multiple tiers to one tray 20. Also, multiple jigs 10 may be fixed to one tier of the tray 20.

[0054] In this way, microneedles can be mass-formed within the pressurized chamber 30 by utilizing a jig 10 on which a large number of microneedle molds 100 can be placed and a tray 20 on which a large number of jigs 10 can be fixed, thereby improving the productivity of microneedles.

[0055] 8 to 13 show examples showing whether or not microneedles are generated for each polymer depending on the internal pressure of the pressure chamber.

[0056] 8 to 13, four kinds of polymers, polyvinyl alcohol (PVA), carboxymethyl cellulose (CMC), polyvinylpyrrolidone (PVP), and hyaluronic acid (HA), were used as raw materials, and the presence or absence of microneedle formation was measured after the pressurization and drying process in a pressure chamber for each polymer. At this time, the ideal maximum size of the microneedle is 650 μm, and the presence or absence of microneedle formation was determined based on whether the tip of the microneedle was formed and whether it had a size of 400 μm or more.

[0057] 8, the four polymers applied to the microneedle mold were subjected to a pressurization and drying process for 48 hours in an environment in which the air pressure injected into the pressurization chamber was 2 bar, the air pressure discharged from the pressurization chamber was 1 bar, and the internal pressure of the pressurization chamber was 1 bar. At this time, it was confirmed that the tips of microneedles were generated for the four polymers, and microneedles having a size of 400 μm or more were not generated.

[0058] 9, the four polymers applied to the microneedle mold were subjected to a pressurization and drying process for 48 hours in an environment in which the air pressure injected into the pressurization chamber was 3 bar, the air pressure discharged from the pressurization chamber was 1 bar, and the internal pressure of the pressurization chamber was 2 bar. At this time, it was confirmed that the tip of the microneedle was generated for the polyvinyl alcohol (PVA) polymer, and that microneedles having a size of 400 μm or more were generated, but that microneedles were not generated for the remaining three polymers.

[0059] 10, the four polymers applied to the microneedle mold were subjected to a pressurization and drying process for 48 hours in an environment where the air pressure injected into the pressurization chamber was 4 bar, the air pressure discharged from the pressurization chamber was 1 bar, and the internal pressure of the pressurization chamber was 3 bar. At this time, it was confirmed that the tip of the microneedle was generated for the polyvinylpyrrolidone (PVP) polymer, and that microneedles having a size of 400 μm or more were generated, but that microneedles were not generated for the remaining three polymers.

[0060] 11, the four polymers applied to the microneedle mold were subjected to a pressurization and drying process for 48 hours in an environment in which the air pressure injected into the pressurization chamber was 5 bar, the air pressure discharged from the pressurization chamber was 1 bar, and the internal pressure of the pressurization chamber was 4 bar. At this time, it was confirmed that the tips of the microneedles were generated for all four polymers, and that the microneedles having a size of 400 μm or more were generated.

[0061] 12, the four polymers applied to the microneedle mold were subjected to a pressurization and drying process for 48 hours in an environment in which the air pressure injected into the pressurization chamber was 6 bar, the air pressure discharged from the pressurization chamber was 1 bar, and the internal pressure of the pressurization chamber was 5 bar. At this time, it was confirmed that the tips of the microneedles were generated for all four polymers, and that microneedles having a size of 400 μm or more were generated.

[0062] 13, the four polymers applied to the microneedle mold were subjected to a pressurization and drying process for 48 hours in an environment in which the air pressure injected into the pressurization chamber was 7 bar, the air pressure discharged from the pressurization chamber was 1 bar, and the internal pressure of the pressurization chamber was 6 bar. At this time, it was confirmed that the tips of the microneedles were generated for all four polymers, and that microneedles having a size of 400 μm or more were generated.

[0063] The above description of the present invention is merely illustrative, and those skilled in the art will understand that the present invention can be easily modified into other specific forms without changing the technical concept or essential features of the present invention. Therefore, the above-described embodiments should be understood to be illustrative and not restrictive in all respects. For example, each component described as a single type may be implemented in a distributed form, and similarly, each component described as a distributed form may be implemented in a combined form.

[0064] The scope of the present invention is defined by the claims set forth below, and all modifications and variations that fall within the meaning and scope of the claims and their equivalent concepts should be construed as being included within the scope of the present invention. [Explanation of symbols]

[0065] 100: Microneedle mold 110: Intaglio part 111: Microstructure 120: Raw materials 10: Jig 20: Tray 30: Pressurized chamber 31: Inlet 32: Outlet

Claims

1. Applying a raw material containing a pharmacological ingredient to one or more recesses formed on the microneedle mold; and The method includes the steps of: inserting the microneedle mold coated with the raw material into a pressure chamber; and compressing the raw material with an internal pressure of the pressure chamber to fill the raw material into the microstructure of the recessed portion; The pressurizing step may include simultaneously injecting and discharging air into and from the pressurizing chamber to generate a convection phenomenon within the pressurizing chamber, thereby simultaneously filling and drying the raw material.

2. 2. The method of claim 1, wherein when the pressure of the air injected into the pressurized chamber is X bar and the pressure of the air discharged from the pressurized chamber is Y bar, the internal pressure of the pressurized chamber (X-Y bar) is 1.5 bar or more.

3. The method for manufacturing a microneedle according to claim 2, wherein the pressure of the air injected into the pressure chamber is 2 bar or more, and the pressure of the air discharged from the pressure chamber is 0.5 bar or more.

4. The method for manufacturing a microneedle according to claim 1 , wherein the microneedle mold is manufactured by injection molding a thermoplastic resin.

5. The method for manufacturing a microneedle according to claim 4, wherein the thermoplastic resin is at least one selected from the group consisting of polyethylene terephthalate (PET), polyvinyl chloride (PVC), and polypropylene (PP).

6. The method for manufacturing a microneedle according to claim 1, wherein the recessed portions of the microneedle mold are tip recessed portions and exist independently of each other.

7. placing a number of microneedle molds on a jig; applying a raw material containing a medicinal ingredient to one or more recesses formed on the microneedle mold; fastening one or more of said fixtures to a tray; and inserting the tray into a pressurized chamber and pressurizing the raw material with an internal pressure of the pressurized chamber to fill the raw material into the microstructures of the recessed portion; The pressurizing step may include simultaneously injecting and discharging air into and from the pressurizing chamber to generate a convection phenomenon within the pressurizing chamber, thereby simultaneously filling and drying the raw material.

8. The method for manufacturing a microneedle according to claim 7, wherein when the pressure of the air injected into the pressurized chamber is X bar and the pressure of the air discharged from the pressurized chamber is Y bar, the internal pressure X-Y bar of the pressurized chamber is 1.5 bar or more.

9. The method for manufacturing a microneedle according to claim 8, wherein the pressure of the air injected into the pressure chamber is 2 bar or more, and the pressure of the air discharged from the pressure chamber is 0.5 bar or more.

Citation Information

Patent Citations

  • Silk fibroin micro-needle system, silk fibroin nanometer particle and preparation method thereof

    CN102580232A

  • Method and apparatus for producing functional membrane

    JP2009082207A

  • Microneedle sheet, its use method and method for producing the same

    JP2010233674A

  • Method of manufacturing needle-shaped body, needle-shaped body and needle-shaped body holding sheet

    JP2011083387A

  • Microneedle, mold for manufacturing the same, and method for manufacturing the same

    JP2016506780A